Sumita Ray - 08 Jan 2023 Form 4 Insider Report for Instil Bio, Inc. (TIL)

Reporting relationship: Chief Legal and Admin Officer
Issuer ticker: TIL
Reported as of: 08 Jan 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Jan 2023, 15:06:29 UTC
Prior SEC filing: 24 Jun 2022
Next SEC filing: 16 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Sandeep Laumas, M.D. Attorney-in-Fact for Sumita Ray, J.D.

Key filing fact

Sumita Ray filed Form 4 for Instil Bio, Inc. (TIL) on 20 Jan 2023.

Key facts

This page summarizes Sumita Ray's Form 4 filing for Instil Bio, Inc. (TIL).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 20 Jan 2023, 15:06.

Change

Previous filing in this sequence was filed on 24 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TIL transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +415,000
Change %
Price: $0.000000
Shares after: 415,000
Date: 08 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 415,000
Exercise price: $0.6340
Footnotes: F1

TIL transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +50,000
Change %
Price: $0.000000
Shares after: 50,000
Date: 18 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $0.7709
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Footnote F2

Twenty-five percent (25%) of the shares subject to the option vest on January 18, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.